Back to results
US 7,605,265 B2Granted
Heterodimers and methods of using them
AssigneeBiotechnology Research Corporation Limited
InventorsNancy Y Ip, Fanny Chui Fun Ip, Yueqing Hu, Yifan Han, Sookja Kim Chung
Life of this patent
Estimating the term…
Abstract
Novel heterodimers of tetrahydroacridines and tetrahydroquinolinones are disclosed. The heterodimers are capable of acting as both acetylcholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists. The heterodimers may be used to improve cognitive defects via treatment or prevention in both humans and non-humans.
Claims4
A compound of Formula I comprising a tetrahydroquinolinone moiety having an amino connecting substituent:
- wherein
- X1, X2 are independently selected from H, alkyl, halo, alkoxy;
- L1, L2, L3, L4 are bonds independently selected from bivalent C1-5 alkylene;
- 1,4-cyclohexylene, 1,4-phenylene, —CO—, —O—, —S— and —NR—;
- R is selected from hydrogen, an unsubstituted or substituted alkyl, an unsubstituted or substituted cycloalkyl, unsubstituted or substituted alkenyl, or unsubstituted or substituted aryl;
- and
- the amino connecting substituent is in either the 5 or 6 position of the tetrahydroquinolinone moiety;
- with the proviso that if the amino connecting substituent of the tetrahydroquinolinone moiety is in the 5 position, and L1-L2-L3-L4 is a C3-12 methylene linker, then one of X1 or X2 is not H.
5 more elements
Dependencies are inferred from the claim text.